دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0039-6257(22)00147-3
Volume 67, Issue 6, November–December 2022, Pages A2-A4
Role of inflammatory cells in pathophysiology and management of diabetic retinopathy
doi : 10.1016/j.survophthal.2022.07.008
Volume 67, Issue 6, November–December 2022, Pages 1563-1573
Diabetic retinopathy (DR) is a sight-threatening complication of diabetes mellitus. Several inflammatory cells and proteins, including macrophages and microglia, cytokines, and vascular endothelial growth factors, are found to play a significant role in the development and progression of DR.
Unconventional avenues to decelerate diabetic retinopathy
Brijesh Takkar, MD a,b,1,∗, Abhishek Sheemar, MD c,1,Rajagopalaboopathi Jayasudha, PhD d, Deepak Soni, MS e,Raja Narayanan, MS a,b, Pradeep Venkatesh, MD f,Sisinthy Shivaji, PhD d, Taraprasad Das, MD a
doi : 10.1016/j.survophthal.2022.06.004
Volume 67, Issue 6, November–December 2022, Pages 1574-1592
Diabetic retinopathy (DR) is an important microvascular complication of diabetes mellitus (DM), causing significant visual impairment worldwide. Current gold standards for retarding the progress of DR include blood sugar control and regular fundus screening. Despite these measures, the incidence and prevalence of DR and vision-threatening DR remain high. Given its slowly progressive course and long latent period, opportunities to contain or slow DR before it threatens vision must be explored.
Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis
James H.B. Im, MPH a, Ya-Ping Jin, MD, PhD a,b, Ronald Chow, MS, FACE,FRSPH c, Riddhi Shah Dharia, MBBS, MS b, Peng Yan, MD, FRCSC b,d,?
doi : 10.1016/j.survophthal.2022.08.002
Volume 67, Issue 6, November–December 2022, Pages 1593-1602
The COVID-19 pandemic disrupted the regular injections of anti-vascular endothelial growth factor (anti-VEGF) in patients with various retinal diseases globally. It is unclear to what extent delayed anti-VEGF injections have worsened patients’ visual acuity. We performed a meta-analysis to assess the impact of delayed anti-VEGF injections on the best-corrected visual acuity (BCVA) in patients with neovascular age-related macular degeneration (nAMD), retinal vein occlusion (RVO), and diabetic macular edema (DME).
An evidence-based review of the epidemiology of myopic traction maculopathy
Kai Xiong Cheong, MD a, Lingqian Xu, PhD a, Kyoko Ohno-Matsui, MD,PhD b, Charumathi Sabanayagam, MD, PhD a,c, Seang Mei Saw, MD,PhD a,c,d, Quan V. Hoang, MD, PhD a,c,e,f,?
doi : 10.1016/j.survophthal.2022.03.007
Volume 67, Issue 6, November–December 2022, Pages 1603-1630
Myopic traction maculopathy (MTM), one of the complications of pathologic myopia, is a spectrum of pathological conditions that are attributed to tractional changes in the eye characterized by retinoschisis, lamellar or full thickness macular hole, and foveal retinal detachment.
Down syndrome and the eye: Ocular characteristics and ocular assessment
Joyce John Mathan, BOptom Hons, Samantha Kaye Simkin, PhD,BOptom Hons, Akilesh Gokul, PhD, BOptom Hons,Charles Ninian John McGhee, DSc FRCOphth
doi : 10.1016/j.survophthal.2022.03.006
Volume 67, Issue 6, November–December 2022, Pages 1631-1646
The trisomy of chromosome 21, the smallest autosome, is associated with significant systemic manifestations in addition to intellectual disability. The triplication of this chromosome, known as Down syndrome (DS) is also associated with several manifestations in the eye, and ocular adnexae. People with DS have a variety of ophthalmic conditions, some of which require intervention.
Update on pediatric corneal diseases and keratoplasty
Murugesan Vanathi, MD a,∗, Nimmy Raj, MD a, Rakhi Kusumesh, MD b,Neelima Aron, MD a, Noopur Gupta, MS a, Radhika Tandon, MD, DNB,FRCOphth, FRCSEd
doi : 10.1016/j.survophthal.2022.07.010
Volume 67, Issue 6, November–December 2022, Pages 1647-1684
Managing pediatric corneal disorders is challenging as the prognosis of pediatric keratoplasty depends on several factors. Advancements in the genetic basis of congenital corneal diseases and investigations in congenital corneal conditions provide a better understanding of pediatric corneal conditions. Surgeons performing keratoplasty in children now have a choice of various techniques.
Treatment compliance in amblyopia: A mini-review and description of a novel online platform for compliance tracking
Tinh Le, MD, Faruk Örge, MD
doi : 10.1016/j.survophthal.2022.08.003
Volume 67, Issue 6, November–December 2022, Pages 1685-1697
Patient compliance with amblyopia therapies, including eye patching and atropine drops, is crucial for optimal visual acuity outcomes. Studies utilizing objective measures of compliance measurement have consistently shown that a majority of patients receive significantly less treatment than prescribed.
Acute postoperative endophthalmitis: Microbiology from the laboratory to the bedside
Christophe Chiquet, MD, PhD a,b,c,∗, Alain M. Bron, MD d,e,Mats Lundstr?m, MD f, Max Maurin, MD, PhD g,h,
doi : 10.1016/j.survophthal.2022.07.001
Volume 67, Issue 6, November–December 2022, Pages 1698-1710
Postoperative endophthalmitis is a dreaded complication of intraocular surgery. Acute presentations need prompt management and good knowledge of differential diagnoses. In the last 10 years, progress in direct microbial detection and identification from intraocular samples included the use of blood culture systems and, more recently, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, improving the rate of bacterial identification. Whatever the method used, diagnostic sensitivity is better for vitreous samples than for aqueous humor samples. Besides, molecular biology techniques have further improved the identification rate of infectious agents in intraocular samples. They also provide faster results compared to culture-based techniques.
At this junction…
Alexander M. Warwick, BS a, Sidney M. Gospe III, MD,PhD a,∗,John J. Chen, MD,PhD b
doi : 10.1016/j.survophthal.2021.08.001
Volume 67, Issue 6, November–December 2022, Pages 1711-1716
An 81-year-old woman developed painful vision loss to hand motions in the right eye over a several-day period. Dilated fundus examination revealed no acute pathology, but automated perimetry showed a superotemporal visual field defect in the asymptomatic left eye, suggestive of a junctional defect. Magnetic resonance imaging demonstrated enhancement of the right optic nerve extending to its junction with the optic chiasm.
Occam versus Hickam
Lucy Cobbs, MD a, Ann P. Murchison, MD a,b,∗, Adam DeBusk, DO c,Jurij R. Bilyk, MD a
doi : 10.1016/j.survophthal.2022.06.001
Volume 67, Issue 6, November–December 2022, Pages 1717-1722
A 23-year-old man presented with new onset horizontal diplopia 5 months after a left orbital floor fracture. Examination revealed bilateral abduction deficits and disc swelling. Urgent MRI and MRI showed no significant abnormalities in the CNS. Lumbar puncture revealed a minimally elevated opening pressure and significant leukocytosis. Additional CSF testing revealed probable Lyme meningitis. The patient responded to a course of oral doxycycline, with rapid resolution of his diplopia, abduction deficits, and disc edema.
Use of an automatic refractometer as a screening tool for pigment dispersion syndrome detection
Paolo Brusini, MD∗Veronica Papa, MD
doi : 10.1016/j.survophthal.2022.07.003
Volume 67, Issue 6, November–December 2022, Page 1723
Authors’ response: Brusini and Papa's comments regarding our review article entitled: “Pigment dispersion syndrome and its implications for glaucoma�
Andres Bustamante-Arias, MDRaul E. Ruiz-Lozano, MDCarlos Alvarez-Guzman, MDSara Gonzalez-Godinez, MDAlejandro Rodriguez-Garcia, MD
doi : 10.1016/j.survophthal.2022.07.002
Volume 67, Issue 6, November–December 2022, Pages 1724-1725
Comments on: Choroidal imaging in uveitis
Paul J. Steptoe, FRCOphthPhilip I. Murray, FRCOphth, PhD
doi : 10.1016/j.survophthal.2022.03.004
Volume 67, Issue 6, November–December 2022, Pages 1726-1727
Authors’ response: Choroidal imaging in uveitis: An update
Abhilasha Baharani, DNB, FRCS, FICOJay Chhablani, MS∗
doi : 10.1016/j.survophthal.2022.03.002
Volume 67, Issue 6, November–December 2022, Page 1728
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia
Devesh Kumawat, MD, FRCSRohan Chawla, MD, FRCS
doi : 10.1016/j.survophthal.2022.07.005
Volume 67, Issue 6, November–December 2022, Pages 1729-1730
Authors’ response: Proliferative retinopathy in chronic myeloid leukemia and diabetes: A “double whammy�
Usman Naeem, MD, Ameen Alkhateeb, MDAbdulqadir J. Nashwan, MSc∗, Mohamed A. Yassin, MBBSMSc
doi : 10.1016/j.survophthal.2022.07.004
Volume 67, Issue 6, November–December 2022, Pages 1731-1732
Comments on: Choroidal thickness in eyes of migraine patients measured using spectral domain-optical coherence tomography: A meta-analysis
Salih Uzun, MDFatma Uzun, MD
doi : 10.1016/j.survophthal.2022.07.007
Volume 67, Issue 6, November–December 2022, Page 1733
Authors’ response: “Choroidal thickness in eyes of migraine patients measured using spectral domain-optical coherence tomography: A meta-analysis�
Soheil Mohammadi, MD, MPH1 , MohammadJ. Fernando Arevalo, MD, PhD
doi : 10.1016/j.survophthal.2022.07.009
Volume 67, Issue 6, November–December 2022, Pages 1734-1735
Comments on: The clinical and pathogenic spectrum of surgically-induced scleral necrosis
DannyLamTyler R. BlahIan C. Francis
doi : 10.1016/j.survophthal.2022.01.014
Volume 67, Issue 6, November–December 2022, Pages 1736-1737
Authors’ response: Lam D, Blah TR, Francis IC. Letter to the Editor regarding the publication: “The clinical and pathogenic spectrum of surgically-induced scleral necrosis�
Raul E. Ruiz-Lozano, MD, Lucas A. Garza-Garza, MD,C. Stephen Foster, MD, FACSAlejandro Rodriguez-Garcia, MD
doi : 10.1016/j.survophthal.2022.01.013
Volume 67, Issue 6, November–December 2022, Pages 1738-1740
